Stockscreener 앱 받기
0.06%
시간 외 거래:
Amgen Inc 주식(AMGN)의 최신 뉴스
Amgen stock holds steady as biotech pipeline and U.S. market presence underpin long-term growth narr - ad-hoc-news.de
Amgen stock reflects biotech heavyweight's steady role in US healthcare - ad-hoc-news.de
Munich Reinsurance Co Stock Corp in Munich Sells 2,916 Shares of Amgen Inc. $AMGN - MarketBeat
Ibex Wealth Advisors Increases Stake in Amgen Inc. $AMGN - MarketBeat
First Horizon Corp Boosts Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Regeneron Cites Medtronic Ruling In Amgen Bundling Case - Law360
Amgen Inc. stock outperforms competitors despite losses on the day - MarketWatch
How AI Is Changing Drug Discovery and What It Will Take to Unlock Its Full Potential - Amgen
Truist Raises its Price Target on Amgen (AMGN) - Insider Monkey
Amgen (AMGN): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance
Amgen stock responds to obesity drug progress and solid pipeline momentum - AD HOC NEWS
Sumitomo Mitsui Trust Group Inc. Lowers Holdings in Amgen Inc. $AMGN - MarketBeat
Greenwood Capital Associates LLC Boosts Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen highlights its biotech pipeline as a driver for long-term growth - Ad-hoc-news.de
RBC Capital Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $370 - Moomoo
Amgen highlights oncology pipeline progress as a major biotech on Nasdaq - Ad-hoc-news.de
The Future of Genus Patenting Strategies for Antibodies Post- Amgen - IPWatchdog.com
Amgen Ecovation®: How Amgen Builds Sustainability Into Biotech - Amgen
Regeneron Narrows Amgen Challenges in Case Over Eylea Biosimilar - Bloomberg Law News
Amgen extends its biotech footprint as a major U.S. pharma player - Ad-hoc-news.de
BBH vs. XPH: Which Healthcare ETF Is Better for Beginners? - The Motley Fool
Amgen Inc. $AMGN Holdings Cut by Swedbank AB - MarketBeat
Amgen Inc. focuses on biotechnology leadership as investors track long-term growth drivers - Ad-hoc-news.de
Amgen focuses on long-term growth as a leading biotech innovator - Ad-hoc-news.de
Regeneron Ducks Amgen's Eylea Antitrust Counterclaims - Law360
How Safe Is Amgen's Dividend? - The Motley Fool
Amgen focuses on pipeline and strategy as investors watch earnings trajectory - AD HOC NEWS
Integrated Advisors Network LLC Raises Stock Holdings in Amgen Inc. $AMGN - MarketBeat
If You Invested $100 In Amgen Stock 15 Years Ago, You Would Have This Much Today - Benzinga
Kiley Juergens Wealth Management LLC Takes $1.25 Million Position in Amgen Inc. $AMGN - MarketBeat
Hodges Capital Management Inc. Increases Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc growth story and pipeline outlook - AD HOC NEWS
Amgen Inc. $AMGN Shares Sold by Burney Co. - MarketBeat
AMGN Maintained by Truist Securities -- Price Target Raised to $340 - GuruFocus
Amgen highlights its science-driven pipeline as investors weigh long-term growth - AD HOC NEWS
Amgen stock leans on its pipeline. Investors track a U.S. biotech giant. - AD HOC NEWS
Amgen highlights biotech strength as a large-cap innovator - AD HOC NEWS
Amgen’s Assembly and Packaging Facility, Ohio, US - Packaging Gateway
Amgen (AMGN) Stock Dips While Market Gains: Key Facts - Yahoo Finance
2026 Best Places to Work in Kentucky rankings announced - pmg-ky1.com
Amgen (AMGN) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Amgen Slides as Tavneos Scrutiny and Pipeline Questions Weigh on Shares - Quiver Quantitative
AMGN Reiterated by Cantor Fitzgerald -- Price Target Maintained at $350 - GuruFocus
Nike, Amgen Share Losses Lead Dow's 238-Point Drop - Moomoo
Cantor Fitzgerald reiterates Amgen stock Neutral rating at $350 - Investing.com
Cantor Fitzgerald reiterates Amgen stock Neutral rating at $350 By Investing.com - Investing.com Canada
Amgen Inc. $AMGN Shares Bought by Stephens Inc. AR - MarketBeat
Amgen Inc. highlights its biotech scale as investors weigh long-term growth - AD HOC NEWS
Amgen Inc. (AMGN) Stock Analysis: Evaluating the 101% Return on Equity Amid a Diverse Portfolio - DirectorsTalk Interviews
Dividend Assets Capital LLC Sells 9,002 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. Stock 12‑Month Price Target Raised to $355.04, Implies 5% Downside - TradingView
Ascentis Independent Advisors Acquires 8,192 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen (AMGN) Could Be 45% Below Fair Value As Court Blocks Enbrel Price Cap - simplywall.st
AMGNAMGEN Inc Latest SEC Filings - Finviz
Amgen Stock: What Happened After a Judge Blocks Colorado’s Enbrel Price Cap? - TIKR.com
Vivid Wealth Management LLC Invests $2.46 Million in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Purchased by QRG Capital Management Inc. - MarketBeat
Amgen Inc. $AMGN Shares Sold by Simplify Asset Management Inc. - MarketBeat
Boston Trust Walden Corp Purchases 12,647 Shares of Amgen Inc. $AMGN - MarketBeat
Y Intercept Hong Kong Ltd Takes $11.40 Million Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Peregrine Asset Advisers Inc. - MarketBeat
Strs Ohio Cuts Stake in Amgen Inc. $AMGN - MarketBeat
Amgen Fights to Keep Avacopan on Market Amid Rising Concerns - Medscape
Amgen Inc. $AMGN Position Boosted by Elevation Point Wealth Partners LLC - MarketBeat
Amgen Inc. $AMGN Shares Sold by Fideuram Intesa Sanpaolo Private Banking S.P.A. - MarketBeat
Fjarde AP Fonden Fourth Swedish National Pension Fund Acquires 62,190 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen (AMGN) Stock Is Up, What You Need To Know - Yahoo Finance
A Look at Amgen Inc (AMGN) After 3.5% Gain -- GF Value $353.58 v - GuruFocus
1.23%
3.72%
자본화:
|
볼륨(24시간):